Condition
CIN2 clinical trials and research
As of November 12, 2026, Find a Trial lists 6 CIN2 clinical trials that are recruiting, at sites in 4 countries (most in South Africa (2), China (2), Czechia (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest CIN2 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Low-thermal Argon Plasma Devitalization for CIN2 Treatment | — | Tübingen, Baden-Wurttemberg | Recruiting | Jul 28, 2026 |
| Assessing regression of cervical precancerous lesions and risk factors | — | Prague | Recruiting | Nov 27, 2023 |
| Urine HPV testing for cervical cancer screening in HIV-infected women in South Africa | — | Westdene, Johannesburg | Recruiting | Jun 10, 2022 |
| Assessing immune response after HPV vaccination in women | — | Yangchun, Guangdong and 1 other locations | Recruiting | May 12, 2022 |
| Evaluating a 9-valent HPV vaccine in healthy Chinese women | Phase 3 | Liuzhou, Guangxi | Recruiting | Jun 9, 2020 |
| Screening for cervical pre-cancer and cancer prevention in South African women | — | Pretoria, Gauteng | Recruiting | Nov 4, 2016 |
All recruiting trials (6)
-
Low-thermal Argon Plasma Devitalization for CIN2 Treatment
This study tests whether a low-thermal argon plasma treatment can heal CIN2 on the cervix better than a sham procedure or active surveillance in women aged 18–40.
-
Assessing regression of cervical precancerous lesions and risk factors
This study is testing how well certain treatments help women with severe cervical precancerous lesions get better and if there are specific factors that can predict their recovery.
-
Urine HPV testing for cervical cancer screening in HIV-infected women in South Africa
This study tests whether using urine samples to check for HPV can help screen for cervical cancer in women living with HIV in South Africa.
-
Assessing immune response after HPV vaccination in women
This study is testing how long the immune protection lasts in Chinese women aged 9-45 after they complete the full HPV vaccination schedule.
-
Evaluating a 9-valent HPV vaccine in healthy Chinese women
This study is testing a new 9-valent HPV vaccine in healthy Chinese women aged 20-45 to see how well it works and if it's safe for preventing HPV-related cancers.
-
Screening for cervical pre-cancer and cancer prevention in South African women
This study is testing new ways to screen for cervical pre-cancer and cancer in South African women to help catch the disease early and improve prevention efforts.
Related topics
Quick answers
How many CIN2 clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in South Africa (2 trials), China (2 trials), Czechia (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.